Patent: 9,364,567
✉ Email this page to a colleague
Summary for Patent: 9,364,567
Title: | Fragments of p97 and uses thereof |
Abstract: | Provided are fragments of human p97 (melanotransferrin) polypeptides having blood-brain barrier (BBB) transport activity, including variants and combinations thereof, conjugates comprising the p97 fragments, and related methods of use thereof, for instance, to facilitate delivery of therapeutic or diagnostic agents across the BBB. |
Inventor(s): | Vitalis; Timothy Z. (Vancouver, CA), Gabathuler; Reinhard (Montreal, CA) |
Assignee: | biOasis Technologies, Inc. (Richmond, CA) |
Application Number: | 14/210,029 |
Patent Claims: | see list of patent claims |
Details for Patent 9,364,567
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Aytu Bioscience, Inc. | PROSTASCINT | capromab pendetide | Injection | 103608 | 10/28/1996 | ⤷ Try a Trial | 2033-03-13 |
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2033-03-13 |
Idec Pharmaceuticals Corp. | RITUXAN | rituximab | Injection | 103737 | 02/19/2002 | ⤷ Try a Trial | 2033-03-13 |
Hoffmann-la Roche Inc. | ZENAPAX | daclizumab | Injection | 103749 | 12/10/1997 | ⤷ Try a Trial | 2033-03-13 |
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2033-03-13 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |